Policy News – Page 4

Sumitomo Pharma Oncology, Inc. Pursues Research and Discovery with Persistence – Featured in Pharma Tech Outlook

Posted on July 5, 2022 by Denise Bell

Sumitomo Pharma Oncology, Inc. (SMP Oncology) and Steve Warner, Ph.D., Senior Vice President and Head of US Research at SMP Oncology, were recently featured in a Pharma Tech Outlook. In “Sumitomo Pharma Oncology: Discovering Immunotherapy Agents with Persistence,” Dr. Warner discusses SMP Oncology’s ongoing work in immunotherapy drug discovery, highlighting the progress with the Company’s […]

Sen. Romney Opposes Drug Importation as the Senate HELP Committee Advances User Fees

Posted on June 17, 2022 by Press Release

The Senate Health, Education, Labor and Pensions (HELP) Committee voted 13 to 9 on Tuesday to advance user fee reauthorization legislation. […]

Invest Lithuania

Posted on June 10, 2022 by Denise Bell

BioUtah has established a partnership with Invest Lithuania, an arm of the Lithuanian government focused on developing life sciences in their country. The life sciences sector in Lithuania is regarded as one of the most highly developed in Central and Eastern Europe (CEE). The sector is driven by innovation and aims to become Europe’s next […]

E&C Leaders Unveil FDA User Fees Legislative Package

Posted on June 10, 2022 by admin

Bipartisan Agreement Will Support Innovation, Lower Costs, and Improve People’s Lives Washington, D.C. – Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ), Ranking Member Cathy McMorris Rodgers (R-WA), Health Subcommittee Chairwoman Anna G. Eshoo (D-CA), and Health Subcommittee Ranking Member Brett Guthrie (R-KY) today unveiled a comprehensive legislative package to reauthorize the Food and Drug […]

CURTIS, CRAIG INTRODUCE BILL TO IMPROVE ACCESS TO GENERIC TREATMENTS

Posted on April 7, 2022 by Press Release

CURTIS, CRAIG INTRODUCE BILL TO IMPROVE ACCESS TO GENERIC TREATMENTS […]

Healthcare Priorities of President Biden’s FY23 Budget

Posted on March 31, 2022 by Denise Bell

On Monday, March 28, President Biden announced his budget for FY23, a $5.8 trillion proposal that reflects the administration’s funding priorities, many of which were drawn from the initial Build Back Better package. Congress is not required to adopt any or all of the president’s budget. However, each year, the president’s budget proposal serves as […]

FACT SHEET: The Biden Administration’s Historic Investment in Pandemic Preparedness and Biodefense in the FY 2023 President’s Budget

Posted on March 31, 2022 by Press Release

The Biden Administration’s Investment in Pandemic Preparedness and Biodefense in the FY 2023 President’s Budget […]

MDUFA V Agreement Reached

Posted on March 29, 2022 by Denise Bell

The FDA and representatives from the medical device industry have reached an agreement on proposed recommendations for MDUFA V. On March 22, FDA sent the commitment letter to Congress. Under the new agreement, the FDA would be authorized to collect at least $1.78 billion in user fees over five years. FDA could receive additional funding […]

Senate HELP Committee Advances PREVENTS Pandemic Act

Posted on March 16, 2022 by Press Release

The Senate HELP Committee on Tuesday voted 20-2 to advance legislation, the PREVENTS Pandemic Act. […]

Reps. Stewart and Curtis Health Staff Tour Life Sciences Companies

Posted on February 28, 2022 by Denise Bell

Over the last couple of weeks, health legislative staff for Utah Reps. Chris Stewart (R-UT) and John Curtis (R-UT) have been touring a number of the state’s life sciences companies to learn more about their innovative work and our growing BioHive. Colleen Malloy White, on behalf of Curtis, visited IONIQ Sciences, ARUP Laboratories and ATL […]

Transition Plan for Medical Devices Issued FDA EUAs

Posted on January 6, 2022 by Denise Bell

To help fight the pandemic, the FDA has been issuing EUAs and exercising enforcement discretion for medical devices needed to diagnose, treat, or prevent COVID-19. Last month, the agency issued two draft guidances related to transition plans to regular compliance for COVID-19 related medical devices that fall under EUAs or Agency Enforcement Policies that have […]

Salt Lake Tribune Features IONIQ Sciences Breast Cancer Screening Technology

Posted on December 22, 2021 by Denise Bell

In a sign that our BioHive is truly buzzing, the Salt Lake Tribune, recently ran an article on advances in breast cancer detection, highlighting the innovative breast cancer screening technology being developed by IONIQ Sciences. The article notes that IONIQ has teamed up with IONIQ scientific advisor and University of Utah assistant professor, Dr. Benjamin […]